ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fibromyalgia Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7J1343
Home | Market Reports | Health| Health Conditions| Pain Management
Global Fibromyalgia Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Fibromyalgia Treatment Market Research Report 2025

Code: QYRE-Auto-7J1343
Report
July 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Allergan plc
Aptinyx Inc
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
Company
Eli Lilly and Company
Pfizer Inc

Fibromyalgia Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Fibromyalgia Treatment Market

Fibromyalgia Treatment Market

The global market for Fibromyalgia Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors).
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Treatment.
The Fibromyalgia Treatment market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fibromyalgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fibromyalgia Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fibromyalgia Treatment Market Report

Report Metric Details
Report Name Fibromyalgia Treatment Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly and Company, Pfizer, Novartis AG, Allergan, Aptinyx, Prismic Pharmaceuticals, Innovative Med Concepts, Intec Pharma Ltd., Astellas Pharma, Savella, Sun Pharmaceutical Industries, Mylan NV, Teva Pharmaceutical Industries, Daiichi Sankyo, Forest Pharmaceuticals, Meiji Seika Pharma, Tonix Pharmaceuticals, Theravance Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Fibromyalgia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Fibromyalgia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Fibromyalgia Treatment Market report?

Ans: The main players in the Fibromyalgia Treatment Market are Eli Lilly and Company, Pfizer, Novartis AG, Allergan, Aptinyx, Prismic Pharmaceuticals, Innovative Med Concepts, Intec Pharma Ltd., Astellas Pharma, Savella, Sun Pharmaceutical Industries, Mylan NV, Teva Pharmaceutical Industries, Daiichi Sankyo, Forest Pharmaceuticals, Meiji Seika Pharma, Tonix Pharmaceuticals, Theravance Biopharma

What are the Application segmentation covered in the Fibromyalgia Treatment Market report?

Ans: The Applications covered in the Fibromyalgia Treatment Market report are Hospitals Pharmacies, Clinic Pharmacy, Retail Drug Stores, Online Pharmacies

What are the Type segmentation covered in the Fibromyalgia Treatment Market report?

Ans: The Types covered in the Fibromyalgia Treatment Market report are Antidepressants, Anticonvulsants, Muscle Relaxants, Narcotic Analgesics, Non-narcotic Analgesics

Recommended Reports

Pain Management

Rheumatology & Musculoskeletal

Autoimmune & Chronic Disease

1 Fibromyalgia Treatment Market Overview
1.1 Product Definition
1.2 Fibromyalgia Treatment by Type
1.2.1 Global Fibromyalgia Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antidepressants
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 Narcotic Analgesics
1.2.6 Non-narcotic Analgesics
1.3 Fibromyalgia Treatment by Application
1.3.1 Global Fibromyalgia Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospitals Pharmacies
1.3.3 Clinic Pharmacy
1.3.4 Retail Drug Stores
1.3.5 Online Pharmacies
1.4 Global Fibromyalgia Treatment Market Size Estimates and Forecasts
1.4.1 Global Fibromyalgia Treatment Revenue 2020-2031
1.4.2 Global Fibromyalgia Treatment Sales 2020-2031
1.4.3 Global Fibromyalgia Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Fibromyalgia Treatment Market Competition by Manufacturers
2.1 Global Fibromyalgia Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Fibromyalgia Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Fibromyalgia Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Fibromyalgia Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fibromyalgia Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fibromyalgia Treatment, Product Type & Application
2.7 Global Key Manufacturers of Fibromyalgia Treatment, Date of Enter into This Industry
2.8 Global Fibromyalgia Treatment Market Competitive Situation and Trends
2.8.1 Global Fibromyalgia Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fibromyalgia Treatment Players Market Share by Revenue
2.8.3 Global Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fibromyalgia Treatment Market Scenario by Region
3.1 Global Fibromyalgia Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Fibromyalgia Treatment Sales by Region: 2020-2031
3.2.1 Global Fibromyalgia Treatment Sales by Region: 2020-2025
3.2.2 Global Fibromyalgia Treatment Sales by Region: 2026-2031
3.3 Global Fibromyalgia Treatment Revenue by Region: 2020-2031
3.3.1 Global Fibromyalgia Treatment Revenue by Region: 2020-2025
3.3.2 Global Fibromyalgia Treatment Revenue by Region: 2026-2031
3.4 North America Fibromyalgia Treatment Market Facts & Figures by Country
3.4.1 North America Fibromyalgia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Fibromyalgia Treatment Sales by Country (2020-2031)
3.4.3 North America Fibromyalgia Treatment Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fibromyalgia Treatment Market Facts & Figures by Country
3.5.1 Europe Fibromyalgia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Fibromyalgia Treatment Sales by Country (2020-2031)
3.5.3 Europe Fibromyalgia Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fibromyalgia Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Fibromyalgia Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Fibromyalgia Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Fibromyalgia Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fibromyalgia Treatment Market Facts & Figures by Country
3.7.1 Latin America Fibromyalgia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Fibromyalgia Treatment Sales by Country (2020-2031)
3.7.3 Latin America Fibromyalgia Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fibromyalgia Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Fibromyalgia Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Fibromyalgia Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Fibromyalgia Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fibromyalgia Treatment Sales by Type (2020-2031)
4.1.1 Global Fibromyalgia Treatment Sales by Type (2020-2025)
4.1.2 Global Fibromyalgia Treatment Sales by Type (2026-2031)
4.1.3 Global Fibromyalgia Treatment Sales Market Share by Type (2020-2031)
4.2 Global Fibromyalgia Treatment Revenue by Type (2020-2031)
4.2.1 Global Fibromyalgia Treatment Revenue by Type (2020-2025)
4.2.2 Global Fibromyalgia Treatment Revenue by Type (2026-2031)
4.2.3 Global Fibromyalgia Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Fibromyalgia Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Fibromyalgia Treatment Sales by Application (2020-2031)
5.1.1 Global Fibromyalgia Treatment Sales by Application (2020-2025)
5.1.2 Global Fibromyalgia Treatment Sales by Application (2026-2031)
5.1.3 Global Fibromyalgia Treatment Sales Market Share by Application (2020-2031)
5.2 Global Fibromyalgia Treatment Revenue by Application (2020-2031)
5.2.1 Global Fibromyalgia Treatment Revenue by Application (2020-2025)
5.2.2 Global Fibromyalgia Treatment Revenue by Application (2026-2031)
5.2.3 Global Fibromyalgia Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Fibromyalgia Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Company Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly and Company Fibromyalgia Treatment Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Fibromyalgia Treatment Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Company Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis AG Fibromyalgia Treatment Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Company Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Fibromyalgia Treatment Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Aptinyx
6.5.1 Aptinyx Company Information
6.5.2 Aptinyx Description and Business Overview
6.5.3 Aptinyx Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aptinyx Fibromyalgia Treatment Product Portfolio
6.5.5 Aptinyx Recent Developments/Updates
6.6 Prismic Pharmaceuticals
6.6.1 Prismic Pharmaceuticals Company Information
6.6.2 Prismic Pharmaceuticals Description and Business Overview
6.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Prismic Pharmaceuticals Fibromyalgia Treatment Product Portfolio
6.6.5 Prismic Pharmaceuticals Recent Developments/Updates
6.7 Innovative Med Concepts
6.7.1 Innovative Med Concepts Company Information
6.7.2 Innovative Med Concepts Description and Business Overview
6.7.3 Innovative Med Concepts Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Innovative Med Concepts Fibromyalgia Treatment Product Portfolio
6.7.5 Innovative Med Concepts Recent Developments/Updates
6.8 Intec Pharma Ltd.
6.8.1 Intec Pharma Ltd. Company Information
6.8.2 Intec Pharma Ltd. Description and Business Overview
6.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Intec Pharma Ltd. Fibromyalgia Treatment Product Portfolio
6.8.5 Intec Pharma Ltd. Recent Developments/Updates
6.9 Astellas Pharma
6.9.1 Astellas Pharma Company Information
6.9.2 Astellas Pharma Description and Business Overview
6.9.3 Astellas Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Astellas Pharma Fibromyalgia Treatment Product Portfolio
6.9.5 Astellas Pharma Recent Developments/Updates
6.10 Savella
6.10.1 Savella Company Information
6.10.2 Savella Description and Business Overview
6.10.3 Savella Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Savella Fibromyalgia Treatment Product Portfolio
6.10.5 Savella Recent Developments/Updates
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Company Information
6.11.2 Sun Pharmaceutical Industries Description and Business Overview
6.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sun Pharmaceutical Industries Fibromyalgia Treatment Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.12 Mylan NV
6.12.1 Mylan NV Company Information
6.12.2 Mylan NV Description and Business Overview
6.12.3 Mylan NV Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mylan NV Fibromyalgia Treatment Product Portfolio
6.12.5 Mylan NV Recent Developments/Updates
6.13 Teva Pharmaceutical Industries
6.13.1 Teva Pharmaceutical Industries Company Information
6.13.2 Teva Pharmaceutical Industries Description and Business Overview
6.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Pharmaceutical Industries Fibromyalgia Treatment Product Portfolio
6.13.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.14 Daiichi Sankyo
6.14.1 Daiichi Sankyo Company Information
6.14.2 Daiichi Sankyo Description and Business Overview
6.14.3 Daiichi Sankyo Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Daiichi Sankyo Fibromyalgia Treatment Product Portfolio
6.14.5 Daiichi Sankyo Recent Developments/Updates
6.15 Forest Pharmaceuticals
6.15.1 Forest Pharmaceuticals Company Information
6.15.2 Forest Pharmaceuticals Description and Business Overview
6.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Forest Pharmaceuticals Fibromyalgia Treatment Product Portfolio
6.15.5 Forest Pharmaceuticals Recent Developments/Updates
6.16 Meiji Seika Pharma
6.16.1 Meiji Seika Pharma Company Information
6.16.2 Meiji Seika Pharma Description and Business Overview
6.16.3 Meiji Seika Pharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Meiji Seika Pharma Fibromyalgia Treatment Product Portfolio
6.16.5 Meiji Seika Pharma Recent Developments/Updates
6.17 Tonix Pharmaceuticals
6.17.1 Tonix Pharmaceuticals Company Information
6.17.2 Tonix Pharmaceuticals Description and Business Overview
6.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Tonix Pharmaceuticals Fibromyalgia Treatment Product Portfolio
6.17.5 Tonix Pharmaceuticals Recent Developments/Updates
6.18 Theravance Biopharma
6.18.1 Theravance Biopharma Company Information
6.18.2 Theravance Biopharma Description and Business Overview
6.18.3 Theravance Biopharma Fibromyalgia Treatment Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Theravance Biopharma Fibromyalgia Treatment Product Portfolio
6.18.5 Theravance Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fibromyalgia Treatment Industry Chain Analysis
7.2 Fibromyalgia Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fibromyalgia Treatment Production Mode & Process Analysis
7.4 Fibromyalgia Treatment Sales and Marketing
7.4.1 Fibromyalgia Treatment Sales Channels
7.4.2 Fibromyalgia Treatment Distributors
7.5 Fibromyalgia Treatment Customer Analysis
8 Fibromyalgia Treatment Market Dynamics
8.1 Fibromyalgia Treatment Industry Trends
8.2 Fibromyalgia Treatment Market Drivers
8.3 Fibromyalgia Treatment Market Challenges
8.4 Fibromyalgia Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Allergan plc
Aptinyx Inc
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
Company
Eli Lilly and Company
Pfizer Inc
List of Tables
 Table 1. Global Fibromyalgia Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Fibromyalgia Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Fibromyalgia Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Fibromyalgia Treatment Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Fibromyalgia Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Fibromyalgia Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Fibromyalgia Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Fibromyalgia Treatment Average Price (USD/KG) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Fibromyalgia Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Fibromyalgia Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Fibromyalgia Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Fibromyalgia Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Fibromyalgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Fibromyalgia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Fibromyalgia Treatment Sales by Region (2020-2025) & (KG)
 Table 18. Global Fibromyalgia Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Fibromyalgia Treatment Sales by Region (2026-2031) & (KG)
 Table 20. Global Fibromyalgia Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Fibromyalgia Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Fibromyalgia Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Fibromyalgia Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Fibromyalgia Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Fibromyalgia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Fibromyalgia Treatment Sales by Country (2020-2025) & (KG)
 Table 27. North America Fibromyalgia Treatment Sales by Country (2026-2031) & (KG)
 Table 28. North America Fibromyalgia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Fibromyalgia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Fibromyalgia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Fibromyalgia Treatment Sales by Country (2020-2025) & (KG)
 Table 32. Europe Fibromyalgia Treatment Sales by Country (2026-2031) & (KG)
 Table 33. Europe Fibromyalgia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Fibromyalgia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Fibromyalgia Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Fibromyalgia Treatment Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Fibromyalgia Treatment Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Fibromyalgia Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Fibromyalgia Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Fibromyalgia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Fibromyalgia Treatment Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Fibromyalgia Treatment Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Fibromyalgia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Fibromyalgia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Fibromyalgia Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Fibromyalgia Treatment Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Fibromyalgia Treatment Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Fibromyalgia Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Fibromyalgia Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Fibromyalgia Treatment Sales (KG) by Type (2020-2025)
 Table 51. Global Fibromyalgia Treatment Sales (KG) by Type (2026-2031)
 Table 52. Global Fibromyalgia Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Fibromyalgia Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Fibromyalgia Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Fibromyalgia Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Fibromyalgia Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Fibromyalgia Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Fibromyalgia Treatment Price (USD/KG) by Type (2020-2025)
 Table 59. Global Fibromyalgia Treatment Price (USD/KG) by Type (2026-2031)
 Table 60. Global Fibromyalgia Treatment Sales (KG) by Application (2020-2025)
 Table 61. Global Fibromyalgia Treatment Sales (KG) by Application (2026-2031)
 Table 62. Global Fibromyalgia Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Fibromyalgia Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Fibromyalgia Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Fibromyalgia Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Fibromyalgia Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Fibromyalgia Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Fibromyalgia Treatment Price (USD/KG) by Application (2020-2025)
 Table 69. Global Fibromyalgia Treatment Price (USD/KG) by Application (2026-2031)
 Table 70. Eli Lilly and Company Company Information
 Table 71. Eli Lilly and Company Description and Business Overview
 Table 72. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 73. Eli Lilly and Company Fibromyalgia Treatment Product
 Table 74. Eli Lilly and Company Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 78. Pfizer Fibromyalgia Treatment Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Novartis AG Company Information
 Table 81. Novartis AG Description and Business Overview
 Table 82. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 83. Novartis AG Fibromyalgia Treatment Product
 Table 84. Novartis AG Recent Developments/Updates
 Table 85. Allergan Company Information
 Table 86. Allergan Description and Business Overview
 Table 87. Allergan Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 88. Allergan Fibromyalgia Treatment Product
 Table 89. Allergan Recent Developments/Updates
 Table 90. Aptinyx Company Information
 Table 91. Aptinyx Description and Business Overview
 Table 92. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 93. Aptinyx Fibromyalgia Treatment Product
 Table 94. Aptinyx Recent Developments/Updates
 Table 95. Prismic Pharmaceuticals Company Information
 Table 96. Prismic Pharmaceuticals Description and Business Overview
 Table 97. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 98. Prismic Pharmaceuticals Fibromyalgia Treatment Product
 Table 99. Prismic Pharmaceuticals Recent Developments/Updates
 Table 100. Innovative Med Concepts Company Information
 Table 101. Innovative Med Concepts Description and Business Overview
 Table 102. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 103. Innovative Med Concepts Fibromyalgia Treatment Product
 Table 104. Innovative Med Concepts Recent Developments/Updates
 Table 105. Intec Pharma Ltd. Company Information
 Table 106. Intec Pharma Ltd. Description and Business Overview
 Table 107. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 108. Intec Pharma Ltd. Fibromyalgia Treatment Product
 Table 109. Intec Pharma Ltd. Recent Developments/Updates
 Table 110. Astellas Pharma Company Information
 Table 111. Astellas Pharma Description and Business Overview
 Table 112. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 113. Astellas Pharma Fibromyalgia Treatment Product
 Table 114. Astellas Pharma Recent Developments/Updates
 Table 115. Savella Company Information
 Table 116. Savella Description and Business Overview
 Table 117. Savella Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 118. Savella Fibromyalgia Treatment Product
 Table 119. Savella Recent Developments/Updates
 Table 120. Sun Pharmaceutical Industries Company Information
 Table 121. Sun Pharmaceutical Industries Description and Business Overview
 Table 122. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 123. Sun Pharmaceutical Industries Fibromyalgia Treatment Product
 Table 124. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 125. Mylan NV Company Information
 Table 126. Mylan NV Description and Business Overview
 Table 127. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 128. Mylan NV Fibromyalgia Treatment Product
 Table 129. Mylan NV Recent Developments/Updates
 Table 130. Teva Pharmaceutical Industries Company Information
 Table 131. Teva Pharmaceutical Industries Description and Business Overview
 Table 132. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 133. Teva Pharmaceutical Industries Fibromyalgia Treatment Product
 Table 134. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 135. Daiichi Sankyo Company Information
 Table 136. Daiichi Sankyo Description and Business Overview
 Table 137. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 138. Daiichi Sankyo Fibromyalgia Treatment Product
 Table 139. Daiichi Sankyo Recent Developments/Updates
 Table 140. Forest Pharmaceuticals Company Information
 Table 141. Forest Pharmaceuticals Description and Business Overview
 Table 142. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 143. Forest Pharmaceuticals Fibromyalgia Treatment Product
 Table 144. Forest Pharmaceuticals Recent Developments/Updates
 Table 145. Meiji Seika Pharma Company Information
 Table 146. Meiji Seika Pharma Description and Business Overview
 Table 147. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 148. Meiji Seika Pharma Fibromyalgia Treatment Product
 Table 149. Meiji Seika Pharma Recent Developments/Updates
 Table 150. Tonix Pharmaceuticals Company Information
 Table 151. Tonix Pharmaceuticals Description and Business Overview
 Table 152. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 153. Tonix Pharmaceuticals Fibromyalgia Treatment Product
 Table 154. Tonix Pharmaceuticals Recent Developments/Updates
 Table 155. Theravance Biopharma Company Information
 Table 156. Theravance Biopharma Description and Business Overview
 Table 157. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
 Table 158. Theravance Biopharma Fibromyalgia Treatment Product
 Table 159. Theravance Biopharma Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Fibromyalgia Treatment Distributors List
 Table 163. Fibromyalgia Treatment Customers List
 Table 164. Fibromyalgia Treatment Market Trends
 Table 165. Fibromyalgia Treatment Market Drivers
 Table 166. Fibromyalgia Treatment Market Challenges
 Table 167. Fibromyalgia Treatment Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Fibromyalgia Treatment
 Figure 2. Global Fibromyalgia Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Fibromyalgia Treatment Market Share by Type: 2024 & 2031
 Figure 4. Antidepressants Product Picture
 Figure 5. Anticonvulsants Product Picture
 Figure 6. Muscle Relaxants Product Picture
 Figure 7. Narcotic Analgesics Product Picture
 Figure 8. Non-narcotic Analgesics Product Picture
 Figure 9. Global Fibromyalgia Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Fibromyalgia Treatment Market Share by Application: 2024 & 2031
 Figure 11. Hospitals Pharmacies
 Figure 12. Clinic Pharmacy
 Figure 13. Retail Drug Stores
 Figure 14. Online Pharmacies
 Figure 15. Global Fibromyalgia Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Fibromyalgia Treatment Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Fibromyalgia Treatment Sales (2020-2031) & (KG)
 Figure 18. Global Fibromyalgia Treatment Average Price (USD/KG) & (2020-2031)
 Figure 19. Fibromyalgia Treatment Report Years Considered
 Figure 20. Fibromyalgia Treatment Sales Share by Manufacturers in 2024
 Figure 21. Global Fibromyalgia Treatment Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Fibromyalgia Treatment Players: Market Share by Revenue in Fibromyalgia Treatment in 2024
 Figure 23. Fibromyalgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Fibromyalgia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Fibromyalgia Treatment Sales Market Share by Country (2020-2031)
 Figure 26. North America Fibromyalgia Treatment Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Fibromyalgia Treatment Sales Market Share by Country (2020-2031)
 Figure 30. Europe Fibromyalgia Treatment Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Fibromyalgia Treatment Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Fibromyalgia Treatment Revenue Market Share by Region (2020-2031)
 Figure 38. China Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Fibromyalgia Treatment Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Fibromyalgia Treatment Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Fibromyalgia Treatment Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Fibromyalgia Treatment Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Fibromyalgia Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Fibromyalgia Treatment by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Fibromyalgia Treatment by Type (2020-2031)
 Figure 60. Global Fibromyalgia Treatment Price (USD/KG) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Fibromyalgia Treatment by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Fibromyalgia Treatment by Application (2020-2031)
 Figure 63. Global Fibromyalgia Treatment Price (USD/KG) by Application (2020-2031)
 Figure 64. Fibromyalgia Treatment Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Fibromyalgia Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fibromyalgia Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medications for Fibromyalgia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fibromyalgia Antidepressant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Musculoskeletal Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bone Pain Treatment Market
Medications for Chronic Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
General Musculoskeletal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicine for Osteoarthritis Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Uterine Fibroid Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dysmenorrhea Treatment Market Research Report 2024
Global Neurofibromatosis Treatment Drug Market Insights Forecast to 2030
Systemic Scleroderma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gingivitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fibromyalgia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibromyalgia Drugs Market Research Report 2024
Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Breathing Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Disease Treatment Market Research Report 2024
Myofascial Release Tools Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions